XOLAIR
XOLAIR (omalizumab) is a monoclonal antibody that helps decrease allergic responses in the body. Specifically, it is an anti-IgE antibody used for asthma and chronic idiopathic urticaria (hives). For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. XOLAIR REFERRAL FORM
Venofer
Venofer is indicated to treat iron deficiency anemia (IDA) in adult and pediatric patients (2 years and older) with chronic kidney disease (CKD). For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. VENOFER REFERRAL FORM
UPLIZNA
UPLIZNA (inebilizumab-cdon) is a prescription medicine used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. UPLIZNA REFERRAL FORM
ULTOMIRIS
ULTOMIRIS (ravulizumab-cwvz) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage. ULTOMIRIS is used to treat adults with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare genetic disorder in which defective red blood cells break down prematurely and leak hemoglobin […]
TRUXIMA
TRUXIMA is a medicine used to treat non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. TRUXIMA REFERRAL FORM
TREMFYA
TREMFYA (guselkumab) is the first medication of its kind to be approved by the Food and Drug Administration (FDA) in 2017 to treat adults with moderate to severe plaque psoriasis. In July 2020, the FDA also approved TREMFYA to treat adults with active psoriatic arthritis. For more information, visit the patient website for this drug. […]
TEZSPIRE
TEZSPIRE (tezepelumab-ekko) is an injectable medication for the treatment of adult and pediatric patients (12+) with severe asthma. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. TEZSPIRE REFERRAL FORM
SKYRIZI
SKYRIZI (risankizumab-rzaa) is an intravenous prescription medicine used for the treatment of moderately to severely active Crohn’s disease. For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you. SKYRIZI REFERRAL FORM
Monoferric
Monoferric (ferric derisomaltose) is an iron replacement product used to treat iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory responses to oral iron, and/or who have non-hemodialysis dependent chronic kidney disease. For more information, visit the patient website for this drug. Speak with your healthcare provider to […]
LEQVIO
The liver plays a key role in clearing bad cholesterol (LDL-C) from the blood, but certain proteins in the liver can interfere with this process. LEQVIO uses the body’s natural processes to prevent many of these proteins from forming in the first place, cutting down bad cholesterol for up to 6 months per injection, after […]